Mvasi (bevacizumab-awwb) is used to treat colorectal cancer, lung cancer, glioblastoma, renal cell carcinoma, cervical cancer and ovarian cancer. Mvasi is a biosimilar for avastin (bevacizumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Mvasi may be covered by your Medicare or insurance plan.

With the Patient Assistance Program from Amgen, you can receive your medication free of charge for up to one year.